Malignant neoplasm of overlapping sites of corpus uteri
- C54.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C54.8 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C54.8 – other international versions of ICD-10 C54.8 may differ.
ICD-10-CM Coding Rules
- C54.8 is applicable to female patients.
The following code(s) above C54.8 contain annotation back-references
that may be applicable to C54.8:
Approximate Synonyms
- Cancer of the uterus, overlapping sites
- Malignant neoplasm of overlapping lesion of corpus uteri
- Overlapping malignant neoplasm of body of uterus
- Uterine cancer, overlapping sites of corpus uteri
ICD-10-CM C54.8 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 736 Uterine and adnexa procedures for ovarian or adnexal malignancy with mcc
- 737 Uterine and adnexa procedures for ovarian or adnexal malignancy with cc
- 738 Uterine and adnexa procedures for ovarian or adnexal malignancy without cc/mcc
- 739 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with mcc
- 740 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy with cc
- 741 Uterine and adnexa procedures for non-ovarian and non-adnexal malignancy without cc/mcc
- 754 Malignancy, female reproductive system with mcc
- 755 Malignancy, female reproductive system with cc
- 756 Malignancy, female reproductive system without cc/mcc
Convert C54.8 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change